Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient
group with both insulin & hydrocortisone (patients with concomitant insulin-treated diabetes
& Addison's disease) and collecting information about the administration -time point and
doses- of insulin, hydrocortisone and food intake with the help of new technology to improve
the treatment in all patients treated with both insulin & glucocorticoids.
Phase:
N/A
Details
Lead Sponsor:
Vastra Gotaland Region
Collaborators:
Åke Wibergs Stiftelse Pilloxa Sahlgrenska University Hospital, Sweden The Gothenburg Society of Medicine